Contraceptive Methods and the Impact of Menstruation on Daily Functioning in Women with Sickle Cell Disease

Melissa E Day, Sarah-Jo Stimpson, Mark Rodeghier, Djamila L. Ghafuri, Michael U. Callaghan, Ahmar U. Zaidi, Bryan Hannan, Adetola A. Kassim, Michael R. DeBaun, Deva Sharma

Southern Medical Journal · 2019 · 17 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

OBJECTIVES: Women with sickle cell disease (SCD) are living longer as a result of advances in the care of their underlying disease. With the population growing of women living with SCD, reproductive health issues in this population have become an emphasized area of medical care. We sought to describe current patterns of contraception use, menstruation, and quality-of-life (QOL) measures in women with SCD. METHODS: Using a cross-sectional study design, we administered paper surveys at two academic medical centers to women aged 10 to 55 years with SCD to capture current contraceptive use, characteristics of menstrual cycles, and QOL metrics. RESULTS: = 0.001), compared with those with neither phenomenon (28.2%, 29/103). CONCLUSIONS: Dysmenorrhea and prolonged menstrual bleeding negatively affect the QOL of women with SCD. Menstrual histories and preventive measures for menstruation-related morbidity should be incorporated into routine evaluations of women with SCD.

References

14